BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Umehara H, Nakajima A, Nakamura T, Kawanami T, Tanaka M, Dong L, Kawano M. IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity. Int Immunol 2014;26:585-95. [PMID: 25024397 DOI: 10.1093/intimm/dxu074] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Ibrahem HM. T Cell Roles and Activity in Chronic Sclerosing Sialadenitis as IgG4-Related Disease: Current Concepts in Immunopathogenesis. Autoimmune Dis 2022;2022:5689883. [PMID: 35769404 DOI: 10.1155/2022/5689883] [Reference Citation Analysis]
2 Kubo S, Kanda R, Nawata A, Miyazaki Y, Kawabe A, Hanami K, Nakatsuka K, Saito K, Nakayamada S, Tanaka Y. Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease. RMD Open 2022;8:e002086. [PMID: 35260476 DOI: 10.1136/rmdopen-2021-002086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chavda VP, Vaghasiya DD, Patel AB. Immunoglobulin G4-related disease: Current status. La Presse Médicale 2022. [DOI: 10.1016/j.lpm.2022.104118] [Reference Citation Analysis]
4 Padiyar S, Manwatkar A, Ganapati A, Roy S, Mathew J. Overlap of IgG4-Related disease with autoimmune rheumatic diseases: Report of 2 cases and review of literature. Indian J Rheumatol 2022;0:0. [DOI: 10.4103/injr.injr_265_21] [Reference Citation Analysis]
5 Özdemir-Şimşek Ö, Erfidan G, Arslansoyu-Çamlar S, Alaygut D, Mutlubaş F, Kasap-Demir B. A rare cause of chronic tubulointerstitial nephritis in childhood: Answers. Pediatr Nephrol 2021. [PMID: 34734329 DOI: 10.1007/s00467-021-05326-y] [Reference Citation Analysis]
6 Frasca F, Piticchio T, Le Moli R, Malaguarnera R, Campennì A, Cannavò S, Ruggeri RM. Recent insights into the pathogenesis of autoimmune hypophysitis. Expert Rev Clin Immunol 2021;17:1175-85. [PMID: 34464545 DOI: 10.1080/1744666X.2021.1974297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Michailidou D, Schwartz DM, Mustelin T, Hughes GC. Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy. Front Immunol 2021;12:693192. [PMID: 34305927 DOI: 10.3389/fimmu.2021.693192] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Nagamura N, Imada T. Anti-interferon-gamma autoantibody related disseminated nontuberculous mycobacteriosis with pathological features of immunoglobulin G4-related disease. Immunol Med 2021;:1-6. [PMID: 34033731 DOI: 10.1080/25785826.2021.1914962] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Malone V, Sheahan K. Novel and rare forms of oesophagitis. Histopathology 2021;78:4-17. [PMID: 33382498 DOI: 10.1111/his.14284] [Reference Citation Analysis]
10 Floreani A, Okazaki K, Uchida K, Gershwin ME. IgG4-related disease: Changing epidemiology and new thoughts on a multisystem disease. J Transl Autoimmun 2021;4:100074. [PMID: 33490938 DOI: 10.1016/j.jtauto.2020.100074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Solakhan M, Kısacık B. Is Peyronie's an IgG4-related disease? Eur J Rheumatol 2021;8:27-30. [PMID: 33545024 DOI: 10.5152/eurjrheum.2020.20101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zongfei J, Rongyi C, Xiaomeng C, Lili M, Lingying M, Xiufang K, Xiaomin D, Zhuojun Z, Huiyong C, Ying S, Lindi J. In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease. Front Immunol 2020;11:1272. [PMID: 32733444 DOI: 10.3389/fimmu.2020.01272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sohn KH, Ham J, Chung SJ, Kang HR, Kim HY. Analysis of Innate and Adaptive Immunological Characteristics in Patients with IgG4-Related Disease. Int Arch Allergy Immunol 2020;181:807-12. [PMID: 32629450 DOI: 10.1159/000508699] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Spinelli M, Datta A, Fenandez MAM, Viola P. Pleural chondroid metaplasia in a background of IgG4 plasma cell rich chronic inflammatory infiltrate: report of a rare case with review of literature. Pathologica 2019;111:361-4. [PMID: 31965113 DOI: 10.32074/1591-951X-1-19] [Reference Citation Analysis]
15 Murata Y, Aoe K, Mimura Y. Pleural effusion related to IgG4. Curr Opin Pulm Med 2019;25:384-90. [PMID: 30883447 DOI: 10.1097/MCP.0000000000000581] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Maślińska M, Wojciechowska B, Mańczak M, Kwiatkowska B. Serum immunoglobulin G4 in Sjögren’s syndrome: a pilot study. Rheumatol Int 2020;40:555-61. [DOI: 10.1007/s00296-020-04529-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Borges T, Silva S. IgG4-related disease: How to place it in the spectrum of immune-mediated and rheumatologic disorders? Mod Rheumatol. 2020;30:609-616. [PMID: 31852351 DOI: 10.1080/14397595.2019.1705537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Min SN, Wu LL, Zhang YY, Zhu WX, Cong X, Yu GY. Disruption of tight junction structure contributes to secretory dysfunction in IgG4-related sialadenitis. J Mol Histol 2020;51:33-46. [PMID: 31865502 DOI: 10.1007/s10735-019-09854-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tsuboi H, Honda F, Takahashi H, Ono Y, Abe S, Kondo Y, Matsumoto I, Sumida T. Pathogenesis of IgG4-related disease. Comparison with Sjögren's syndrome. Mod Rheumatol 2020;30:7-16. [PMID: 31425659 DOI: 10.1080/14397595.2019.1650694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
20 Tsuboi H, Iizuka-Koga M, Asashima H, Takahashi H, Kudo H, Ono Y, Honda F, Iizuka A, Segawa S, Abe S, Yagishita M, Yokosawa M, Kondo Y, Moriyama M, Matsumoto I, Nakamura S, Sumida T. Upregulation and pathogenic roles of CCL18-CCR8 axis in IgG4-related disease. Mod Rheumatol 2020;30:729-37. [PMID: 31203743 DOI: 10.1080/14397595.2019.1632061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
21 Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, Iwao H, Miki M, Masaki Y, Okazaki T, Ishigaki Y, Kawano M, Yamada K, Matsui S, Saeki T, Kamisawa T, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tanaka Y, Tsuboi H, Sumida T, Okazaki K, Tanaka M, Chiba T, Mimori T, Umehara H. Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD. Mod Rheumatol 2020;30:551-7. [PMID: 31116057 DOI: 10.1080/14397595.2019.1621475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Yang WT, Tsai KY. A rare case of oral tumor presenting as first sign of immunoglobulin G4-related disease. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:e187-90. [PMID: 31076326 DOI: 10.1016/j.oooo.2019.03.004] [Reference Citation Analysis]
23 Pucar PA, Nolan J, Hissaria P. Immunoglobulin G4 related disease: a single-centre experience from South Australia. Intern Med J 2019;49:1099-104. [PMID: 31059167 DOI: 10.1111/imj.14331] [Reference Citation Analysis]
24 Abbass K, Krug H. Granulomatosis with polyangiitis in a patient with biopsy-proven IgG4-related pulmonary disease and coincident small cell lung cancer. BMJ Case Rep 2019;12:e226280. [PMID: 30872335 DOI: 10.1136/bcr-2018-226280] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
25 Umehara H, Okazaki K, Kawano M, Tanaka Y. The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease? Modern Rheumatology 2019;29:214-8. [DOI: 10.1080/14397595.2018.1558519] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
26 Yamada K, Mizushima I, Kawano M. New insights into the pathophysiology of IgG4-related disease and markers of disease activity. Expert Rev Clin Immunol 2019;15:231-9. [PMID: 30557078 DOI: 10.1080/1744666X.2019.1560268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Leiferman KM, Peters MS. Eosinophil-Related Disease and the Skin. The Journal of Allergy and Clinical Immunology: In Practice 2018;6:1462-1482.e6. [DOI: 10.1016/j.jaip.2018.06.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
28 Umehara H, Kawano M. Response to: 'Serum complement factor C5a in IgG4-related disease' by Fukui et al. Ann Rheum Dis 2019;78:e66. [PMID: 29875098 DOI: 10.1136/annrheumdis-2018-213729] [Reference Citation Analysis]
29 Konno N, Sugimoto M, Takagi T, Furuya M, Asano T, Sato S, Kobayashi H, Migita K, Miura Y, Aihara T, Komatsuda A, Ohira H, Watanabe H. Changes in N-glycans of IgG4 and its relationship with the existence of hypocomplementemia and individual organ involvement in patients with IgG4-related disease. PLoS One 2018;13:e0196163. [PMID: 29672582 DOI: 10.1371/journal.pone.0196163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
30 Salvadori M, Tsalouchos A. Immunoglobulin G4-related kidney diseases: An updated review. World J Nephrol 2018; 7(1): 29-40 [PMID: 29359118 DOI: 10.5527/wjn.v7.i1.29] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
31 Rzepecka A, Babińska A, Sworczak K. IgG4-related disease in endocrine practice. Arch Med Sci 2019;15:55-64. [PMID: 30697253 DOI: 10.5114/aoms.2017.70889] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Kasashima S, Kasashima F, Kawashima A, Endo M, Matsumoto Y, Kawakami K. Clinical Outcomes After Endovascular Repair and Open Surgery to Treat Immunoglobulin G4–Related and Nonrelated Inflammatory Abdominal Aortic Aneurysms. J Endovasc Ther 2017;24:833-45. [DOI: 10.1177/1526602817732316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
33 Wang L, Chu X, Ma Y, Zhang M, Wang X, Jin L, Tan Z, Li X, Li X. A Comparative Analysis of Serum IgG4 Levels in Patients With IgG4-Related Disease and Other Disorders. The American Journal of the Medical Sciences 2017;354:252-6. [DOI: 10.1016/j.amjms.2017.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
34 Murata Y, Aoe K, Mimura-Kimura Y, Murakami T, Oishi K, Matsumoto T, Ueoka H, Matsunaga K, Yano M, Mimura Y. Association of immunoglobulin G4 and free light chain with idiopathic pleural effusion. Clin Exp Immunol 2017;190:133-42. [PMID: 28617941 DOI: 10.1111/cei.12999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
35 Ueda S, Usui Y, Nagai T, Diaz-aguilar D, Nagao T, Goto H. Immunophenotypic profiles for distinguishing orbital mucosa-associated lymphoid tissue lymphoma from benign lymphoproliferative tumors. Jpn J Ophthalmol 2017;61:354-60. [DOI: 10.1007/s10384-017-0513-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
36 Li H, Sun L, Brigstock DR, Qi L, Gao R. IgG4-related sclerosing cholangitis overlapping with autoimmune hepatitis: Report of a case. Pathol Res Pract. 2017;213:565-569. [PMID: 28238541 DOI: 10.1016/j.prp.2017.01.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 Usui Y, Rao NA, Takase H, Tsubota K, Umazume K, Diaz-Aguilar D, Kezuka T, Mochizuki M, Goto H, Sugita S. Comprehensive polymerase chain reaction assay for detection of pathogenic DNA in lymphoproliferative disorders of the ocular adnexa. Sci Rep 2016;6:36621. [PMID: 27830722 DOI: 10.1038/srep36621] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
38 Shibata M, Matsubayashi H, Aramaki T, Uesaka K, Tsutsumi N, Sasaki K, Ono H. A case of IgG4-related hepatic inflammatory pseudotumor replaced by an abscess after steroid treatment. BMC Gastroenterol 2016;16:89. [PMID: 27484098 DOI: 10.1186/s12876-016-0504-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
39 Mann S, Seidman MA, Barbour SJ, Levin A, Carruthers M, Chen LY. Recognizing IgG4-related tubulointerstitial nephritis. Can J Kidney Health Dis 2016;3:34. [PMID: 27429760 DOI: 10.1186/s40697-016-0126-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
40 Ohta M, Moriyama M, Maehara T, Gion Y, Furukawa S, Tanaka A, Hayashida JN, Yamauchi M, Ishiguro N, Mikami Y, Tsuboi H, Iizuka-Koga M, Kawano S, Sato Y, Kiyoshima T, Sumida T, Nakamura S. DNA Microarray Analysis of Submandibular Glands in IgG4-Related Disease Indicates a Role for MARCO and Other Innate Immune-Related Proteins. Medicine (Baltimore) 2016;95:e2853. [PMID: 26886650 DOI: 10.1097/MD.0000000000002853] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
41 Haldar D, Cockwell P, Richter AG, Roberts KJ, Hirschfield GM. An overview of the diagnosis and management of immunoglobulin G4-related disease. CMAJ. 2016;188:953-961. [PMID: 27325130 DOI: 10.1503/cmaj.151402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
42 Corradi D, Nicastro M, Vaglio A. Immunoglobulin G4-related disease: some missing pieces in a still unsolved complex puzzle. Cardiovascular Pathology 2016;25:90-2. [DOI: 10.1016/j.carpath.2015.10.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
43 Lang D, Zwerina J, Pieringer H. IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag 2016;12:189-99. [PMID: 26929632 DOI: 10.2147/TCRM.S99985] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
44 Maillette de Buy Wenniger LJ, Beuers U. Immunoglobulin G4-related cholangiopathy: clinical and experimental insights. Curr Opin Gastroenterol 2015;31:252-7. [PMID: 25730176 DOI: 10.1097/MOG.0000000000000170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
45 Fernández-Codina A, Martínez-Valle F, Pinilla B, López C, DeTorres I, Solans-Laqué R, Fraile-Rodríguez G, Casanovas-Martínez A, López-Dupla M, Robles-Marhuenda Á, Barragán-González MJ, Cid MC, Prieto-González S, Brito-Zerón P, Cruces-Moreno MT, Fonseca-Aizpuru E, López-Torres M, Gil J, Núñez-Fernández MJ, Pardos-Gea J, Salvador-Cervelló G. IgG4-Related Disease: Results From a Multicenter Spanish Registry. Medicine (Baltimore) 2015;94:e1275. [PMID: 26266361 DOI: 10.1097/MD.0000000000001275] [Cited by in Crossref: 76] [Cited by in F6Publishing: 59] [Article Influence: 10.9] [Reference Citation Analysis]
46 Shimizu Y, Yamamoto M, Yajima H, Suzuki C, Naishiro Y, Takahashi H, Imai K, Shinomura Y. Role of interleukin-32 in the mechanism of chronic inflammation in IgG4-related disease and as a predictive biomarker for drug-free remission. Modern Rheumatology 2016;26:391-7. [DOI: 10.3109/14397595.2015.1089973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
47 Islam AD, Selmi C, Datta-Mitra A, Sonu R, Chen M, Gershwin ME, Raychaudhuri SP. The changing faces of IgG4-related disease: Clinical manifestations and pathogenesis. Autoimmun Rev. 2015;14:914-922. [PMID: 26112170 DOI: 10.1016/j.autrev.2015.06.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
48 Fukuhara T, Tomiyama T, Yasuda K, Ueda Y, Ozaki Y, Son Y, Nomura S, Uchida K, Okazaki K, Kinashi T. Hypermethylation of MST1 in IgG4-related autoimmune pancreatitis and rheumatoid arthritis. Biochem Biophys Res Commun 2015;463:968-74. [PMID: 26056943 DOI: 10.1016/j.bbrc.2015.06.043] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
49 Nakajima A, Masaki Y, Nakamura T, Kawanami T, Ishigaki Y, Takegami T, Kawano M, Yamada K, Tsukamoto N, Matsui S, Saeki T, Okazaki K, Kamisawa T, Miyashita T, Yakushijin Y, Fujikawa K, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tsuboi H, Sumida T, Morimoto H, Sato T, Iwao H, Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H. Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease. PLoS One 2015;10:e0126582. [PMID: 25973893 DOI: 10.1371/journal.pone.0126582] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]